This Singapore Research Brings Bad News For Sinovac Vaccine Users

PRFMNEWS- Sinovac is a brand vaccine Covid-19 is the most widely used by the people of Indonesia.

Recently, a study in Singapore revealed the results of a study which stated that people who get vaccine Sinovac almost 5 times more likely to get Covid-19 worse than the recipient vaccine Pfizer.

The study, delivered on Tuesday, April 12, 2022, involved 2.7 million people in Singapore aged 20 years and over who received two doses under the national vaccination program.

Also Read: As a DNA Pro Brand Ambassador, Ivan Gunawan Returns Contract Money to the Criminal Investigation Police

They carried out the study covering a period of 7 seven weeks in 2021 from October 1 to November 21, when the cases of the Delta variant in Singapore were rising sharply.

Infectious disease experts from the National Center for Infectious Diseases (NCID) and the Ministry of Health (MOH) observed the relatively lower effectiveness of the two vaccine inactivated whole virus, i.e Sinovac and Sinopharm against infection Covid-19 compared vaccine mRNA, PfizerBioNTech and Moderna.

Also Read: Ivan Gunawan Responds to Calls from the Criminal Investigation Unit for Police related to DNA Pro fraudulent investments

Quoted from Channel News Asia, the people who received vaccine Sinovac i.e. 4.59 times more likely to suffer Covid-19 severe compared to the recipient vaccine Pfizer-BioNTech.

–